152 related articles for article (PubMed ID: 8045968)
1. Growth hormone therapy in Turner's syndrome: one versus two daily injections.
De Schepper J; Craen M; Massa G; Heinrichs C; Maes M; Du Caju M; Rausin L; Bourguignon JP
J Clin Endocrinol Metab; 1994 Aug; 79(2):489-94. PubMed ID: 8045968
[TBL] [Abstract][Full Text] [Related]
2. Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Dutch Advisory Group on Growth Hormone.
Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; Hokken-Koelega AC; Waelkens JJ; Massa GG; Vulsma T; Gerver WJ; Reeser HM; Delemarre-van de Waal HE; Jansen M; Drop SL
Arch Dis Child; 1999 Jan; 80(1):36-41. PubMed ID: 10325756
[TBL] [Abstract][Full Text] [Related]
3. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome.
Vanderschueren-Lodeweyckx M; Massa G; Maes M; Craen M; van Vliet G; Heinrichs C; Malvaux P
J Clin Endocrinol Metab; 1990 Jan; 70(1):122-6. PubMed ID: 2294126
[TBL] [Abstract][Full Text] [Related]
4. Slow baseline growth and a good response to growth hormone (GH) therapy are related to elevated spontaneous GH pulse frequency in girls with Turner's syndrome.
Kamp GA; Kuilboer MM; Wynne HJ; Rongen-Westerlaken C; Johnson ML; Veldhuis JD; Wit JM
J Clin Endocrinol Metab; 1993 Jun; 76(6):1604-9. PubMed ID: 8501169
[TBL] [Abstract][Full Text] [Related]
5. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
Nilsson KO; Albertsson-Wikland K; Alm J; Aronson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson SA; Karlberg J; Kriström B; Marcus C; Moell C; Ritzen M; Tuvemo T; Wattsgård C; Westgren U; Westphal O; Aman J
J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
[TBL] [Abstract][Full Text] [Related]
6. Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome.
Massa G; Maes M; Heinrichs C; Vandeweghe M; Craen M; Vanderschueren-Lodeweyckx M
Clin Endocrinol (Oxf); 1993 Mar; 38(3):253-60. PubMed ID: 8458097
[TBL] [Abstract][Full Text] [Related]
7. Carbohydrate metabolism during growth hormone treatment and after discontinuation of growth hormone treatment in girls with Turner syndrome treated with once or twice daily growth hormone injections.
Sas T; de Muinck Keizer-Schrama S; Aanstoot HJ; Stijnen T; Drop S
Clin Endocrinol (Oxf); 2000 Jun; 52(6):741-7. PubMed ID: 10848879
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone therapy in Turner's syndrome. Impact of injection frequency and initial bone age.
Rongen-Westerlaken C; van Es A; Wit JM; Otten BJ; De Muinck Keizer-Schrama SM; Drayer NM; Oostdijk W; Delemarre-vd Waal HA; Gons MH; Waelkens JJ
Am J Dis Child; 1992 Jul; 146(7):817-20. PubMed ID: 1496949
[TBL] [Abstract][Full Text] [Related]
9. Growth response and levels of growth factors after two years growth hormone treatment are similar for a once and twice daily injection regimen in girls with Turner syndrome. (Dutch Working Group on Growth Hormone).
van Teunenbroek A; de Muinck Keizer-Schrama S; Stijnen T; Waelkens J; Wit JM; Vulsma T; Gerver WJ; Reeser H; Delemarre-van de Waal H; Jansen M; Drop S
Clin Endocrinol (Oxf); 1997 Apr; 46(4):451-9. PubMed ID: 9196608
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone treatment in Turner's syndrome: short and long-term effects on metabolic parameters.
Haeusler G; Frisch H
Clin Endocrinol (Oxf); 1992 Mar; 36(3):247-53. PubMed ID: 1563078
[TBL] [Abstract][Full Text] [Related]
11. Methionyl human growth hormone in Turner's syndrome.
Rongen-Westerlaken C; Wit JM; Drop SL; Otten BJ; Oostdijk W; Waal HA; Gons MH; Bot A; Van den Brande JL
Arch Dis Child; 1988 Oct; 63(10):1211-7. PubMed ID: 3196048
[TBL] [Abstract][Full Text] [Related]
12. Age-related perception of stature, acceptance of therapy, and psychosocial functioning in human growth hormone-treated girls with Turner's syndrome.
Lagrou K; Xhrouet-Heinrichs D; Heinrichs C; Craen M; Chanoine JP; Malvaux P; Bourguignon JP
J Clin Endocrinol Metab; 1998 May; 83(5):1494-501. PubMed ID: 9589645
[TBL] [Abstract][Full Text] [Related]
13. Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome.
Cacciari E; Mazzanti L
J Clin Endocrinol Metab; 1999 Dec; 84(12):4510-5. PubMed ID: 10599710
[TBL] [Abstract][Full Text] [Related]
14. Effect of growth hormone therapy on thyroid status of girls with Turner's syndrome.
Massa G; de Zegher F; Vanderschueren-Lodeweyckx M
Clin Endocrinol (Oxf); 1991 Mar; 34(3):205-9. PubMed ID: 2036729
[TBL] [Abstract][Full Text] [Related]
15. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
[TBL] [Abstract][Full Text] [Related]
16. Glucose turnover and insulin clearance after growth hormone treatment in girls with Turner's syndrome.
Monti LD; Brambilla P; Caumo A; Magni F; Omati S; Nizzoli G; di Natale B; Galli-Kienle M; Cobelli C; Chiumello G; Pozza G
Metabolism; 1997 Dec; 46(12):1482-8. PubMed ID: 9439548
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of the changes in insulin-like growth factor-I, procollagen-III N-terminal extension peptide, bone Gla-protein, and bone mineral content in children with Turner's syndrome treated with recombinant growth hormone.
Bergmann P; Valsamis J; Van Perborgh J; De Schepper J; Van Vliet G
J Clin Endocrinol Metab; 1990 Dec; 71(6):1461-7. PubMed ID: 2229302
[TBL] [Abstract][Full Text] [Related]
18. Serum growth hormone (GH)-binding protein and insulin-like growth factor-I levels in Turner's syndrome before and during treatment with recombinant human GH and ethinyl estradiol.
Massa G; Bouillon R; Vanderschueren-Lodeweyckx M
J Clin Endocrinol Metab; 1992 Nov; 75(5):1298-302. PubMed ID: 1430092
[TBL] [Abstract][Full Text] [Related]
19. The effect of short term treatment with growth hormone and ethinyl estradiol on lower leg growth rate in girls with Turner's syndrome.
Ross JL; Cassorla F; Carpenter G; Long LM; Royster MS; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1988 Sep; 67(3):515-8. PubMed ID: 3410937
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone therapy in Turner's syndrome: an update on final height. Genentech National Cooperative Study Group.
Rosenfeld RG
Acta Paediatr Suppl; 1992 Sep; 383():3-6; discussion 7. PubMed ID: 1458013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]